NCT06600828

Brief Summary

Internal medicine units treat patients with undifferentiated or multisystem diseases, with a non-specific organ approach. In some cases, patients with single-organ disease may be admitted to internal medicine wards. Acute pancreatitis is the most common gastrointestinal illness requiring acute admission to hospital. It is characterised by local and systemic inflammation of the pancreas corresponding to single-organ disease. For patients with single-organ disease such as acute pancreatitis, it is not known whether admission to internal medicine is as effective as admission to a unit specialising in a specific organ, such as hepato-gastro-enterology.

Trial Health

57
Monitor

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Trial has exceeded expected completion date
Enrollment
140

participants targeted

Target at P50-P75 for all trials

Timeline
Completed

Started Jun 2024

Shorter than P25 for all trials

Geographic Reach
1 country

1 active site

Status
recruiting

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

June 6, 2024

Completed
3 months until next milestone

First Submitted

Initial submission to the registry

September 10, 2024

Completed
9 days until next milestone

First Posted

Study publicly available on registry

September 19, 2024

Completed
6 months until next milestone

Primary Completion

Last participant's last visit for primary outcome

April 1, 2025

Completed
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

April 1, 2025

Completed
Last Updated

September 19, 2024

Status Verified

June 1, 2024

Enrollment Period

10 months

First QC Date

September 10, 2024

Last Update Submit

September 13, 2024

Conditions

Keywords

Internal Medicine Unit efficiencyRetrospective observational studyAcute Pancreatitis

Outcome Measures

Primary Outcomes (1)

  • Performance Stay Length Index

    "Performance Stay Length Index", is a measure used to evaluate the efficiency of hospital care in terms of patients' length of stay. This index is calculated by comparing the average length of stay of patients in a given service to a predefined reference, often based on established standards or goals.

    From the date of inclusion to the date of discharge from hospital, assessed for up to 100 months

Secondary Outcomes (2)

  • Rate of complications at 1 year

    During one year from diagnosis

  • Rate of rehospitalization at 1 year

    During one year from diagnosis

Study Arms (2)

The Internal Medicine Unit arm

It includes all patients hospitalized in the Internal Medicine Unit. Patients may have been previously hospitalized in the emergency department or in another department such as intensive care.

Other: Data collection

The hepato-gastro-enterology Unit arm

It includes all patients hospitalized in the Gastroenterology unit. Patients may have been previously hospitalized in the emergency department or in another department such as intensive care.

Other: Data collection

Interventions

Data collected: Socio-demographic, hospital, clinical, biological, and imaging data

The Internal Medicine Unit armThe hepato-gastro-enterology Unit arm

Eligibility Criteria

Age18 Years+
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)
Sampling MethodNon-Probability Sample
Study Population

All adult patients hospitalized from January 1, 2022, to December 31, 2023 in the University Hospital of Saint Etienne with a primary diagnosis of acute pancreatitis in Internal Medicine and gastroenterology will be included.

You may qualify if:

  • adult patient
  • primary diagnosis of acute pancreatitis in Internal Medicine and gastroenterology.

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

CHU de Saint-Etienne

Saint-Etienne, 42055, France

RECRUITING

MeSH Terms

Conditions

Pancreatitis

Interventions

Data Collection

Condition Hierarchy (Ancestors)

Pancreatic DiseasesDigestive System Diseases

Intervention Hierarchy (Ancestors)

Epidemiologic MethodsInvestigative TechniquesHealth Care Evaluation MechanismsQuality of Health CareHealth Care Quality, Access, and EvaluationPublic HealthEnvironment and Public Health

Study Officials

  • Kyria REGALADE, resident

    CHU SAINT-ETIENNE

    PRINCIPAL INVESTIGATOR

Central Study Contacts

Kyria REGALADE, resident

CONTACT

Study Design

Study Type
observational
Observational Model
COHORT
Time Perspective
RETROSPECTIVE
Sponsor Type
OTHER
Responsible Party
SPONSOR

Study Record Dates

First Submitted

September 10, 2024

First Posted

September 19, 2024

Study Start

June 6, 2024

Primary Completion

April 1, 2025

Study Completion

April 1, 2025

Last Updated

September 19, 2024

Record last verified: 2024-06

Data Sharing

IPD Sharing
Will not share

Locations